Review
[Arsenic trioxide in the treatment of acute promyelocytic leukaemia]
[Article in
Spanish]
Affiliations
- PMID: 12717564
Item in Clipboard
Review
[Arsenic trioxide in the treatment of acute promyelocytic leukaemia]
[Article in
Spanish]
Farm Hosp.
2003 Mar-Apr.
Abstract
Arsenic trioxide has drawn renewed interest in onco-haematological therapy. Based on a number of studies quoted in this paper, it has been approved by FDA and EMEA for remission induction and consolidation therapy of acute promyelocytic leukaemia in patients refractory to treatment using trans-retinoic acid and anthracyclines. In addition to briefly discuss available therapeutic resources against this disease, this review attempts to provide an in-depth view of this drugâs characteristics and efficacy, as shown in several studies.
Similar articles
-
Arsenic trioxide and acute promyelocytic leukemia: clinical and biological.Curr Top Microbiol Immunol. 2007;313:129-44. doi: 10.1007/978-3-540-34594-7_8. Curr Top Microbiol Immunol. 2007. PMID: 17217042 Review.
-
Two cases of monocular visual loss during oral arsenic trioxide therapy of acute promyelocytic leukemia.Am J Hematol. 2009 Oct;84(10):699. doi: 10.1002/ajh.21505. Am J Hematol. 2009. PMID: 19705432 No abstract available.
-
Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience.Eur J Haematol. 2013 Dec;91(6):483-9. doi: 10.1111/ejh.12194. Epub 2013 Sep 17. Eur J Haematol. 2013. PMID: 24033687
-
Ancient remedy performs new tricks.Science. 1996 Aug 2;273(5275):578. doi: 10.1126/science.273.5275.578. Science. 1996. PMID: 8701308 No abstract available.
-
Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.Best Pract Res Clin Haematol. 2014 Mar;27(1):39-52. doi: 10.1016/j.beha.2014.04.003. Epub 2014 Apr 12. Best Pract Res Clin Haematol. 2014. PMID: 24907016 Review.